• PDF: Delivered by email usually within 12 to 48 UK business hours.

The Future of Contract Manufacturing
Market Forecasts to 2015

  • Publication Date:December 2009
  • Publisher:GBI Research
  • Product Type: Report
  • Pages:67

The Future of Contract Manufacturing Market Forecasts to 2015

Summary

GBI Research, the leading business intelligence provider, has released its latest research 'The Future of Contract Manufacturing Market Forecasts to 2015 and Key Trends'. The report provides key data, information and analysis of the global contract manufacturing market. Further the report provides comprehensive information on the different service models present in the industry, key trends affecting contract manufacturing organizations and analytical content on the market dynamics. The report also reviews the competitive landscape, mergers and acquisitions, strategic partnerships and service agreements.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

The scope of this report includes:

  • Annualized market data for the global contract manufacturing market from 2000 to 2008, with forecasts to 2015
  • Data and analysis on the global contract manufacturing market in the leading geographies of the world - the US, the UK, Germany, France, Italy, Spain, and Japan.
  • Key drivers and restraints that have a significant impact on the market
  • Information on the cost, developmental and regulatory issues facing contract manufacturing.
  • Competitive landscape of global contract manufacturing market including benchmarking of top companies. The key companies studied in this report are Jubilent Biosciences, Piramal Healthcare, Lonza Biologics, Catalant, DSM, Sandoz and Boehringer Ingelheim.
  • Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global contract manufacturing market.

Reasons to buy

The report will aid business development and marketing executives strategizing their product launches:

  • Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
  • Develop key strategic initiatives by studying the key strategies of top competitors.
  • Identify key players best positioned to take advantage of the emerging market opportunities
  • Overcome the regulatory hurdles in the contract manufacturing outsourcing market
  • Exploit in-licensing and out-licensing opportunities by identifying key trends that might probably fill their portfolio gaps.
  • Make informed decisions related to the M&A activities in the contract manufacturing outsourcing market
  • 1 Tables and Figures
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 GBI Research Report Guidance
  • 3 Industry Overview
    • 3.1 CMO Industry Structure
    • 3.2 Types of Outsourcing
      • 3.2.1 Onshoring
      • 3.2.2 Offshoring
      • 3.2.3 Nearshoring
    • 3.3 Applications of CMOs
      • 3.3.1 Primary Development
      • 3.3.2 Pre-Formulation Studies and Formulation Development
      • 3.3.3 Dosage Creation
      • 3.3.4 Primary and Secondary Manufacturing
      • 3.3.5 Packaging
  • 4 Global CMO Market – Market Characterization
    • 4.1 Market Forecasts
  • 5 Geographical Landscape
    • 5.1 Introduction
    • 5.2 Emerging Markets
      • 5.2.1 The Indian CMO Market
      • 5.2.2 The Chinese CMO Market
  • 6 Market Drivers and Restraints
    • 6.1 Market Drivers
      • 6.1.1 Increased Utilization of Biologics for Disease Therapy
      • 6.1.2 Increase in Demand for Generics
      • 6.1.3 Providing End-To-End Solutions
      • 6.1.4 Increase in Number of Government Sanctions and Policies Favoring CMOs
    • 6.2 Market Restraints
      • 6.2.1 Complex Cost Structures in Outsourcing
      • 6.2.2 The Complex Manufacturing Procedures for Biopharmaceuticals
      • 6.2.3 Reduced number of Drug Approvals
  • 7 Regulatory Framework
    • 7.1 Overview
    • 7.2 FDA Guidelines
      • 7.2.1 Organization and Personnel
      • 7.2.2 Building and Facilities
      • 7.2.3 Process Equipment
      • 7.2.4 Control of Raw Materials
      • 7.2.5 Production and Process Controls
      • 7.2.6 Packaging and Labeling
      • 7.2.7 Holding and Distribution
      • 7.2.8 Key Changes in FDA Guidelines
    • 7.3 EMEA Guidelines
      • 7.3.1 Quality Management
      • 7.3.2 Production Activities
      • 7.3.3 Buildings and Facilities
      • 7.3.4 Process Equipment
      • 7.3.5 Materials Management
      • 7.3.6 Packaging and labeling
      • 7.3.7 Key Changes in EMEA Guidelines
  • 8 Key Aspects of the CMO Industry
    • 8.1 The Need for Outsourcing
      • 8.1.1 Change in Pharmaceutical Industry Structure
      • 8.1.2 Key Benefits of Outsourcing
    • 8.2 Key Outsourcing Models
      • 8.2.1 Mixed Sourcing Model
      • 8.2.2 Sale Leaseback Model
    • 8.3 Management of CMO Manufacturing
      • 8.3.1 Choosing the Right CMO
      • 8.3.2 Key Steps Involved in Executing Projects
      • 8.3.3 Risk Assessment
  • 9 Key CMO Participants
    • 9.1 Catalent
    • 9.2 Lonza
    • 9.3 Piramal Healthcare
    • 9.4 Jubilant Organosys
    • 9.5 Royal DSM N.V.
    • 9.6 Evonik
    • 9.7 Patheon
    • 9.8 Fareva
    • 9.9 Cambrex
    • 9.10 Boehringer Ingelheim
  • 10 Strategic Consolidations within the Global CMO Market
    • 10.1 Overview
    • 10.2 Agreements
      • 10.2.1 The key agreements that have taken place since 2008 have been discussed below.
    • 10.3 Mergers and Collaborations
      • 10.3.1 The notable mergers and collaborations that have taken place since 2008 are discussed below.
    • 10.4 Acquisitions
      • 10.4.1 The key acquisition that have taken place since 2008 are discussed below.
  • 11 Appendix
    • 11.1 Market Definitions
    • 11.2 Abbreviations
    • 11.3 Research Methodology
      • 11.3.1 Coverage
      • 11.3.2 Secondary Research
      • 11.3.3 Primary Research
      • 11.3.4 Expert Panel Validation
    • 11.4 Contact Us
    • 11.5 Disclaimer
    • 11.6 Sources
  • List of Tables
    • Table 1: CMO Market, India, Key CMO Agreements, 2005-2007
    • Table 2: CMO Market, China, Leading Biopharmaceuticals Companies in China, 2008
    • Table 3: CMO Market, Global, Major Drug Patent Expirations, 2008-2015
  • List of Figures
    • Figure 1: CMO Market, Global, Basic Services Provided, 2008
    • Figure 2: CMO Market, Global, CMO Industry Structure, 2008
    • Figure 3: CMO Market, Global, Key Applications of CMOs, 2008
    • Figure 4: CMO Market, Global, Key Steps in API Manufacturing, 2008
    • Figure 5: CMO Market, Global, Revenue Forecasts, 2006-2015
    • Figure 6: CMO Market, Global, Market Share by Services Provided, 2008
    • Figure 7: CMO Market, Global, Key Geographical Trends, 2008
    • Figure 8: CMO Market, Global, Market Share by Geographic Area, 2008
    • Figure 9: CMO Market, Global, Percentage Split of Manufacturing Portfolio By Geographic Regions, 2008
    • Figure 10: CMO Market, India, Key Factors Driving Outsourcing, 2008
    • Figure 11: CMO Market, India, Revenue Forecasts, 2006-2015
    • Figure 12: CMO Market, India, Key Concerns for Outsourcing, 2008
    • Figure 13: CMO Market, China, Key Factors Driving Outsourcing, 2008
    • Figure 14: CMO Market. Global, Assessment of API Manufacturing by Region, 2007
    • Figure 15: CMO Market, China, Revenue Forecast ($bn), 2006-2015
    • Figure 16: CMO Market, Global, Key Market Drivers and Restraints, 2008
    • Figure 17: CMO Market, Global, Forecasts for Sales Between Conventional Drugs and Biologics, 2006-2015
    • Figure 18: CMO Market, Global, Biologic Drugs Under Development, 2008
    • Figure 19: CMO Market, Global, CMOs Providing Overall Pharmaceutical Solutions, 2008
    • Figure 20: CMO Market, Global, FDA Drug Approvals of NDAs and NBEs, 2000-2008
    • Figure 21: CMO Market, Global, EMEA Guidelines for API Production, 2008
    • Figure 22: CMO Market, Global, Market Lifecycle, 2008
    • Figure 23: CMO Market, Global, Fragmentation of the Pharmaceutical Industry, 2008
    • Figure 24: CMO Market, Global, Key Benefits of Outsourcing, 2008
    • Figure 25: CMO Market, Global, Mixed Source Model, 2008
    • Figure 26: CMO Market, Global, Sale-Leaseback Model, 2008
    • Figure 27: CMO Market, Global, Key Points While Considering CMOs, 2008
    • Figure 28: CMO Market, Global, Responsibilities of Sponsor and CMO on Various Aspects of Manufacturing, 2008
    • Figure 29: CMO Market, Global, Key Points While Considering CMOs, 2008
    • Figure 30: CMO Market, Global, Company Profiles - Catalent, 2008
    • Figure 31: CMO Market, Global, Company Profiles – Lonza, 2008
    • Figure 32: CMO Market, Global, Company Profiles – Piramal Healthcare, 2008
    • Figure 33: CMO Market, Global, Company Profiles – Jubilant Organosys , 2008
    • Figure 34: CMO Market, Global, Company Profiles – DSM, 2008
    • Figure 35: CMO Market, Global, Company Profiles – Evonik, 2008
    • Figure 36: CMO Market, Global, Company Profiles – Patheon, 2008
    • Figure 37: CMO Market, Global, Company Profiles – Fareva, 2008
    • Figure 38: CMO Market, Global, Company Profiles – Cambrex, 2008
    • Figure 39: CMO Market, Global, Company Profiles – Boehringer Ingelheim, 2008
    • Figure 40: CMO Market, Global, Strategic Consolidations Split by Agreements Type and Geography, 2008
    • Figure 41: CMO Market, Global, Strategic Consolidations Split by Agreements Type and Geography, 2008
    • Figure 42: GBI Research Methodology
+44 20 8816 8548

Ask a question about The Future of Contract Manufacturing

Enter the characters you see in the picture below
Captcha